Atlas Capital Advisors LLC Novartis Ag Transaction History

Atlas Capital Advisors LLC

$640 Billion
Q1 2024

A detailed history of Atlas Capital Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 732 shares of NVS stock, worth $77,914. This represents 0.01% of its overall portfolio holdings.

Number of Shares

732

Previous 5,624 86.98%

Holding current value

$77,914

Previous $568 Million 87.53%

% of portfolio

0.01%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$95.27 - $108.47 $466,060 - $530,635	-4,892 Reduced 86.98%	732 $70.8 Million
Q4 2023 Feb 15, 2024	BUY	$92.27 - $101.54 $148,001 - $162,870	1,604 Added 39.9%	5,624 $568 Million
Q4 2022 Feb 15, 2023	SELL	$75.55 - $92.52 $12,616 - $15,450	-167 Reduced 3.99%	4,020 $365 Million
Q3 2022 Nov 08, 2022	SELL	$74.61 - $87.26 $225,247 - $263,437	-3,019 Reduced 41.9%	4,187 $318 Million
Q2 2022 Aug 16, 2022	SELL	$80.52 - $93.75 $368,942 - $429,562	-4,582 Reduced 38.87%	7,206 $609 Million

Q4 2021 Feb 01, 2022	BUY	$79.7 - $88.13 $216,704 - $239,625	2,719 Added 29.98%	11,788 $1.03 Billion
Q3 2021 Oct 28, 2021	BUY	$81.78 - $95.14 $398,186 - $463,236	4,869 Added 115.93%	9,069 $741,000
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $180,610 - $212,990	-2,163 Reduced 33.99%	4,200 $359,000
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $11,896 - $13,391	-147 Reduced 2.26%	6,363 $555,000
Q1 2020 May 04, 2020	SELL	$70.67 - $99.01 $435,680 - $610,396	-6,165 Reduced 48.64%	6,510 $536,000
Q4 2019 Jan 28, 2020	SELL	$84.35 - $95.37 $85,446 - $96,609	-1,013 Reduced 7.4%	12,675 $1.2 Million
Q3 2019 Nov 01, 2019	BUY	$85.54 - $94.26 $87,165 - $96,050	1,019 Added 8.04%	13,688 $1.19 Million
Q2 2019 Jul 25, 2019	BUY	$75.4 - $92.8 $147,256 - $181,238	1,953 Added 18.23%	12,669 $0
Q1 2019 Apr 29, 2019	BUY	$75.32 - $86.15 $325,156 - $371,909	4,317 Added 67.46%	10,716 $0
Q4 2018 Jan 29, 2019	BUY	$73.66 - $82.02 $176,710 - $196,765	2,399 Added 59.98%	6,399 $492,000
Q2 2018 Jul 30, 2018	SELL	$64.91 - $73.36 $269,765 - $304,884	-4,156 Reduced 50.96%	4,000 $0
Q1 2018 Apr 18, 2018	BUY	$70.39 - $84.15 $574,100 - $686,327	8,156 New	8,156 $0

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Novartis Ag Transaction History